EA008389B1 - Способ получения производных 5-(1,3-оксазол-2-ил)бензойной кислоты - Google Patents

Способ получения производных 5-(1,3-оксазол-2-ил)бензойной кислоты Download PDF

Info

Publication number
EA008389B1
EA008389B1 EA200401510A EA200401510A EA008389B1 EA 008389 B1 EA008389 B1 EA 008389B1 EA 200401510 A EA200401510 A EA 200401510A EA 200401510 A EA200401510 A EA 200401510A EA 008389 B1 EA008389 B1 EA 008389B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
formula
alkyl
compounds
reaction mixture
Prior art date
Application number
EA200401510A
Other languages
English (en)
Russian (ru)
Other versions
EA200401510A1 (ru
Inventor
Майкл Р. Ридер
Рик Дж. Имбордино
Original Assignee
Фармация Энд Апджон Компани Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон Компани Ллс filed Critical Фармация Энд Апджон Компани Ллс
Publication of EA200401510A1 publication Critical patent/EA200401510A1/ru
Publication of EA008389B1 publication Critical patent/EA008389B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
EA200401510A 2002-06-20 2003-06-20 Способ получения производных 5-(1,3-оксазол-2-ил)бензойной кислоты EA008389B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
EA200401510A1 EA200401510A1 (ru) 2005-06-30
EA008389B1 true EA008389B1 (ru) 2007-04-27

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401510A EA008389B1 (ru) 2002-06-20 2003-06-20 Способ получения производных 5-(1,3-оксазол-2-ил)бензойной кислоты

Country Status (17)

Country Link
US (2) US7115747B2 (cg-RX-API-DMAC7.html)
EP (1) EP1532123B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005533811A (cg-RX-API-DMAC7.html)
CN (1) CN1324017C (cg-RX-API-DMAC7.html)
AT (1) ATE370131T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003249344A1 (cg-RX-API-DMAC7.html)
BR (1) BR0312439A (cg-RX-API-DMAC7.html)
CA (1) CA2489988A1 (cg-RX-API-DMAC7.html)
CO (1) CO5670350A2 (cg-RX-API-DMAC7.html)
DE (1) DE60315664D1 (cg-RX-API-DMAC7.html)
EA (1) EA008389B1 (cg-RX-API-DMAC7.html)
IL (1) IL165763A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012630A (cg-RX-API-DMAC7.html)
NO (1) NO20045497L (cg-RX-API-DMAC7.html)
NZ (1) NZ537390A (cg-RX-API-DMAC7.html)
PL (1) PL374999A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004000821A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040762A1 (es) * 2002-11-27 2004-11-06 Elan Pharm Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
MX2011002705A (es) 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002512A2 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
WO2003029169A2 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
WO2003040096A2 (en) * 2001-11-08 2003-05-15 Elan Pharmaceuticals, Inc. N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002512A2 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
WO2003029169A2 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
WO2003040096A2 (en) * 2001-11-08 2003-05-15 Elan Pharmaceuticals, Inc. N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
B.J. ANDERSON, N.K. HARN: SYNTHESIS, 1996, pages 583-585, XP001154931, cited in the application, the whole document *

Also Published As

Publication number Publication date
US7115747B2 (en) 2006-10-03
BR0312439A (pt) 2005-05-10
ATE370131T1 (de) 2007-09-15
DE60315664D1 (de) 2007-09-27
CN1662510A (zh) 2005-08-31
US20040063965A1 (en) 2004-04-01
CA2489988A1 (en) 2003-12-31
MXPA04012630A (es) 2005-09-30
PL374999A1 (en) 2005-11-14
EA200401510A1 (ru) 2005-06-30
US20070105921A1 (en) 2007-05-10
WO2004000821A1 (en) 2003-12-31
EP1532123A1 (en) 2005-05-25
NZ537390A (en) 2006-07-28
CN1324017C (zh) 2007-07-04
CO5670350A2 (es) 2006-08-31
JP2005533811A (ja) 2005-11-10
NO20045497D0 (no) 2004-12-16
IL165763A0 (en) 2006-01-15
EP1532123B1 (en) 2007-08-15
NO20045497L (no) 2005-03-07
AU2003249344A1 (en) 2004-01-06
HK1081543A1 (zh) 2006-05-19

Similar Documents

Publication Publication Date Title
US7115747B2 (en) Process for preparing oxazole intermediates
CN102786516B (zh) 一种利伐沙班的合成方法
JP2010254709A (ja) バルサルタンの製造方法
CN107879992B (zh) 一种(1-甲基-1h-[1,2,4]三唑-3-基)-甲醇的制备方法
RU2510395C2 (ru) Способ получения доцетаксела
KR20080072738A (ko) 아미도-페녹시벤조산 화합물의 제조를 위한 화학적 방법
EP3478684B1 (en) New processes for the preparation of vemurafenib
WO2016115962A1 (zh) 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法
WO1998057923A1 (en) New production process
JP7373241B2 (ja) ピリミジニルビピリジン化合物の製造方法及びそのための中間体
KR20050019766A (ko) 5-(1,3-옥사졸-2-일)벤조산 유도체의 제조 방법
JP3233806B2 (ja) スルフェニル酢酸誘導体の製造法
JPH0641066A (ja) ピロール誘導体の製造方法
Kang et al. Synthesis and Biological Evaluations of N-(2-Substituted-1-carboxyl) vinylazetidinones: A Study on the Essential Structural Element for Biological Activities of ${\beta} $-Lactam Antibiotics
KR100208297B1 (ko) 신규한 세펨 유도체의 제조방법
KR880001540B1 (ko) 세팔로스포린의 제조방법
CN115215853A (zh) 一种作为法尼醇x受体激动剂的化合物的制备方法
CN116375703A (zh) 一种阿哌沙班的合成工艺
JPS5835513B2 (ja) ウロカニン酸エチルエステルの製造法
CN102020658A (zh) 一种新型化合物及其制备方法
JPS59163325A (ja) カルボン酸エステルの製造法
JPS60115567A (ja) ３−アミノイソオキサゾ−ル類の製法
JPS59106475A (ja) テトラゾ−ル誘導体及びその製法
JPS59112975A (ja) ４−置換イソオキサゾ−ル類の製造法
HK1081543B (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives